Abstract
Inflammatory bowel disease (IBD) is a group of chronic non-specific inflammatory disorders which affects the gastrointestinal tract. The etiology and pathology are still unclear which may be associated with the change of intestinal microbiota, intestinal infections, compromised intestinal mucosal barrier integrity, dysregulated immune responses in gut mucosa and genetic susceptibility. With great progress of IBD studies in recent years, intestinal microbiota has been found to play a crucial role in the pathogenesis of IBD. In this article, we summarize the latest researches on intestinal microbiota which regulates mucosal immune responses and novel translational studies on microbiota alteration in the diagnosis and therapy in IBD. Key words: Inflammatory bowel disease; Intestinal microbiota; Intestinal mucosal immunity
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
